July 11, 2018 / 9:41 PM / 7 months ago

Generic drugmaker owes Shire $1.5 million in fees after sanction

A federal judge on Wednesday awarded Adderall XR maker Shire PLC more than $1.5 million to cover attorneys’ fees and expenses it incurred dealing with a generic drug company’s “litigation misconduct” in the course of a patent infringement lawsuit.

U.S. District Judge William Young in Boston issued the award after he previously sanctioned Abhai LLC for not revealing until mid-trial that it had discovered errors in its testing data for its planned generic version of extended-release Adderall.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2L6xFoc

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below